Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease

被引：5
|
作者：
Zhao, Li-Min [1 ]
Zhan, Ze-Lin [2 ]
Ning, Jie [1 ]
Qiu, Mei [3 ]
机构：
[1] Shenzhen Longhua Dist Cent Hosp, Dept Endocrinol, Shenzhen, Peoples R China
[2] Southern Med Univ, Clin Med, Clin Med Coll 2, Guangzhou, Peoples R China
[3] Shenzhen Longhua Dist Cent Hosp, Dept Gen Med, Shenzhen, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 12卷
关键词：
SGLT2; inhibitors; finerenone; type; 2; diabetes; chronic kidney disease; renal failure; heart failure; CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN; EFFICACY;
D O I：
10.3389/fphar.2021.751496
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Cardiorenal Effects of Sglt2 Inhibitors and Finerenone in Type 2 Diabetes and Chronic Kidney Disease. Single, Dual or Triple Therapy? A Network Meta-Analysis
    Acevedo, Jesus Diaz
    Lazcano, Greilys
    Soto, Mariana
    Castro, Adela
    Penaherrera, Carlos
    Buitrago, Andres F.
    Narayanankutty, Naveen Punchayil
    Navas, Viviana
    Pino, Jesus E.
    CIRCULATION, 2022, 146
  • [2] Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
    Zhang, Yaofu
    Jiang, Li
    Wang, Junheng
    Wang, Tongxin
    Chien, Chieh
    Huang, Weijun
    Fu, Xiaozhe
    Xiao, Yonghua
    Fu, Qiang
    Wang, Shidong
    Zhao, Jinxi
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [3] Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
    Yaofu Zhang
    Li Jiang
    Junheng Wang
    Tongxin Wang
    Chieh Chien
    Weijun Huang
    Xiaozhe Fu
    Yonghua Xiao
    Qiang Fu
    Shidong Wang
    Jinxi Zhao
    Cardiovascular Diabetology, 21
  • [4] Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis
    Li, Ning
    Lv, Dan
    Zhu, Xiangjun
    Wei, Ping
    Gui, Yuan
    Liu, Shijia
    Zhou, Enchao
    Zheng, Min
    Zhou, Dong
    Zhang, Lu
    FRONTIERS IN MEDICINE, 2021, 8
  • [5] Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease
    Yaofu Zhang
    Junheng Wang
    Li Jiang
    Tongxin Wang
    Zhuang Li
    Xiaozhe Fu
    Weijun Huang
    Yonghua Xiao
    Shidong Wang
    Jinxi Zhao
    Diabetology & Metabolic Syndrome, 14
  • [6] Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease
    Zhang, Yaofu
    Wang, Junheng
    Jiang, Li
    Wang, Tongxin
    Li, Zhuang
    Fu, Xiaozhe
    Huang, Weijun
    Xiao, Yonghua
    Wang, Shidong
    Zhao, Jinxi
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [7] Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis
    McGuire, Darren K.
    Shih, Weichung J.
    Cosentino, Francesco
    Charbonnel, Bernard
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Pratley, Richard
    Greenberg, Michelle
    Wang, Shuai
    Huyck, Susan
    Gantz, Ira
    Terra, Steven G.
    Masiukiewicz, Urszula
    Cannon, Christopher P.
    JAMA CARDIOLOGY, 2021, 6 (02) : 148 - 158
  • [8] The effects of the SGLT2 inhibitors on the Japanese type 2 diabetes patients with chronic kidney disease
    Kobayashi, K.
    Sato, K.
    Hatori, N.
    Miyakawa, M.
    Toyoda, M.
    DIABETOLOGIA, 2017, 60 : S418 - S418
  • [9] Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes A meta-analysis
    Zou, Cai-Yan
    Liu, Xue-Kui
    Sang, Yi-Quan
    Wang, Ben
    Liang, Jun
    MEDICINE, 2019, 98 (49)
  • [10] Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Kelly, Michael S.
    Lewis, Jelena
    Huntsberry, Ashley M.
    Dea, Lauren
    Portillo, Ivan
    POSTGRADUATE MEDICINE, 2019, 131 (01) : 31 - 42
12345